NASDAQ:DH Definitive Healthcare (DH) Stock Price, News & Analysis → The Best AI Stock to Own in the World Today is Trading for Just $25 (From Banyan Hill Publishing) (Ad) Free DH Stock Alerts $7.27 -0.06 (-0.82%) (As of 04/23/2024 ET) Add Compare Share Share Today's Range$7.24▼$7.5750-Day Range$7.04▼$10.2652-Week Range$5.53▼$12.45Volume733,074 shsAverage Volume530,770 shsMarket Capitalization$856.33 millionP/E RatioN/ADividend YieldN/APrice Target$11.31 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media Get Definitive Healthcare alerts: Email Address Definitive Healthcare MarketRank™ Stock AnalysisAnalyst RatingHold2.22 Rating ScoreUpside/Downside55.6% Upside$11.31 Price TargetShort InterestBearish15.57% of Float Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment0.60Based on 4 Articles This WeekInsider TradingN/AProj. Earnings Growth27.27%From $0.11 to $0.14 Per ShareSee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.2.91 out of 5 starsMedical Sector418th out of 909 stocksPrepackaged Software Industry118th out of 196 stocks 3.1 Analyst's Opinion Consensus RatingDefinitive Healthcare has received a consensus rating of Hold. The company's average rating score is 2.22, and is based on 2 buy ratings, 7 hold ratings, and no sell ratings.Amount of Analyst CoverageDefinitive Healthcare has only been the subject of 2 research reports in the past 90 days. Previous Next 0.0 Short Interest Percentage of Shares Shorted15.57% of the float of Definitive Healthcare has been sold short.Short Interest Ratio / Days to CoverDefinitive Healthcare has a short interest ratio ("days to cover") of 13.4, which indicates bearish sentiment.Change versus previous monthShort interest in Definitive Healthcare has recently increased by 54.04%, indicating that investor sentiment is decreasing significantly. Previous Next 0.0 Dividend Strength Dividend YieldDefinitive Healthcare does not currently pay a dividend.Dividend GrowthDefinitive Healthcare does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for DH. Previous Next 3.7 News and Social Media Coverage News SentimentDefinitive Healthcare has a news sentiment score of 0.60. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.44 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 4 news articles for Definitive Healthcare this week, compared to 2 articles on an average week.Search Interest4 people have searched for DH on MarketBeat in the last 30 days. This is an increase of 100% compared to the previous 30 days.MarketBeat Follows2 people have added Definitive Healthcare to their MarketBeat watchlist in the last 30 days. This is an increase of 100% compared to the previous 30 days. Previous Next 2.5 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Definitive Healthcare insiders have not sold or bought any company stock.Percentage Held by Insiders15.27% of the stock of Definitive Healthcare is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions98.67% of the stock of Definitive Healthcare is held by institutions. High institutional ownership can be a signal of strong market trust in this company. Previous Next 2.5 Earnings and Valuation Earnings GrowthEarnings for Definitive Healthcare are expected to grow by 27.27% in the coming year, from $0.11 to $0.14 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Definitive Healthcare is -4.08, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Definitive Healthcare is -4.08, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Growth RatioDefinitive Healthcare has a PEG Ratio of 6.38. PEG Ratios above 1 indicate that a company could be overvalued.Price to Book Value per Share RatioDefinitive Healthcare has a P/B Ratio of 0.71. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here Ad WealthPressThe system that called 2023’s top 7 stocks is at it again…Look 2023 kind of sucked from a trading standpoint… Despite the market finishing 24% higher…. Just seven stocks did all of the work… Unless you were holding or actively trading those 7 stocks, your trading year probably wasn’t as fruitful as you had hoped… According to my research, my new trading system would have spotted all seven of the “Magnificent stocks” MONTHS before they reached the highs they are trading at today.Just follow this link here! About Definitive Healthcare Stock (NASDAQ:DH)Definitive Healthcare Corp., together with its subsidiaries, provides software as a service (SaaS) healthcare commercial intelligence platform in the United States and internationally. Its SaaS platform provides information on healthcare providers and their activities to help its customers from product development to go-to-market planning, and sales and marketing execution. The company's platform consists of various functional areas, such as sales, marketing, clinical research and product development, strategy, talent acquisition, and physician network management. It serves biopharmaceutical and medical device companies, healthcare information technology companies, and healthcare providers; and other diversified companies comprising staffing and commercial real estate firms, financial institutions, and other organizations in the healthcare ecosystem. The company was founded in 2011 and is headquartered in Framingham, Massachusetts.Read More DH Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart DH Stock News HeadlinesApril 23, 2024 | globenewswire.comDefinitive Healthcare Announces Timing of Its First Quarter 2024 Financial Results Conference Call and WebcastApril 23, 2024 | americanbankingnews.comDefinitive Healthcare Corp. (NASDAQ:DH) Given Consensus Recommendation of "Hold" by BrokeragesApril 24, 2024 | WealthPress (Ad)$25,000 into $109,616 in two months? Today I want to show you how our research shows you could’ve grown a $25,000 account into $109,616.12 within the last TWO months. You see, former multi-million dollar hedge fund manager Roger Scott spent the better half of 2023 developing what might be the most advanced trading tool that exists… It’s a revolutionary software system that tracks the moves of institutional investors…. in real time…April 16, 2024 | finance.yahoo.comDefinitive Healthcare introduces Carevoyance sales enablement solution for medtech industryMarch 22, 2024 | markets.businessinsider.comVML and Definitive Healthcare announce partnership to transform key opinion leader managementMarch 22, 2024 | globenewswire.comVML and Definitive Healthcare announce partnership to transform key opinion leader managementMarch 21, 2024 | markets.businessinsider.comNeedham Reaffirms Their Hold Rating on Definitive Healthcare Corp (DH)March 20, 2024 | morningstar.comDefinitive Healthcare Corp Class AApril 24, 2024 | WealthPress (Ad)$25,000 into $109,616 in two months? Today I want to show you how our research shows you could’ve grown a $25,000 account into $109,616.12 within the last TWO months. You see, former multi-million dollar hedge fund manager Roger Scott spent the better half of 2023 developing what might be the most advanced trading tool that exists… It’s a revolutionary software system that tracks the moves of institutional investors…. in real time…March 19, 2024 | seekingalpha.comDefinitive Healthcare: Reiterate Buy Rating As I Expect Growth To Recover In FY25March 16, 2024 | finance.yahoo.comDH Apr 2024 5.000 putMarch 16, 2024 | finance.yahoo.comDH Jul 2024 5.000 putMarch 14, 2024 | globenewswire.comDefinitive Healthcare earns 2024 Middle Market Leader Award from Boston Business JournalMarch 2, 2024 | finance.yahoo.comDefinitive Healthcare Corp. (NASDAQ:DH) Just Released Its Annual Earnings: Here's What Analysts ThinkMarch 1, 2024 | markets.businessinsider.comHold Rating on Definitive Healthcare Amid Leadership Changes and Revenue UncertaintiesMarch 1, 2024 | markets.businessinsider.comWhat 4 Analyst Ratings Have To Say About Definitive HealthcareFebruary 29, 2024 | markets.businessinsider.comMaintaining Hold on Definitive Healthcare Corp Amidst Transition and Mixed Growth SignalsFebruary 29, 2024 | markets.businessinsider.comChallenging Times For Definitive Healthcare: Analysts Highlight Sluggish Growth And Recovery Efforts In Q4 AnalysisFebruary 29, 2024 | finanznachrichten.deDefinitive Healthcare Corp.: Definitive Healthcare Reports Financial Results for Fourth Quarter and Full Fiscal Year 2023February 28, 2024 | seekingalpha.comDefinitive Healthcare Corp. 2023 Q4 - Results - Earnings Call PresentationFebruary 28, 2024 | msn.comDefinitive Healthcare reports Q4 resultsFebruary 28, 2024 | finance.yahoo.comDefinitive Healthcare Corp Reports Mixed Results Amidst Growth and ChallengesFebruary 28, 2024 | globenewswire.comDefinitive Healthcare Reports Financial Results for Fourth Quarter and Full Fiscal Year 2023February 27, 2024 | benzinga.comEarnings Outlook For Definitive HealthcareFebruary 17, 2024 | finance.yahoo.comDH Mar 2024 10.000 callFebruary 14, 2024 | finance.yahoo.comDefinitive Healthcare Announces Timing of Its Fourth Quarter and Full Year 2023 Financial Results Conference Call and WebcastFebruary 14, 2024 | globenewswire.comDefinitive Healthcare Announces Timing of Its Fourth Quarter and Full Year 2023 Financial Results Conference Call and WebcastSee More Headlines Receive DH Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Definitive Healthcare and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings2/28/2024Today4/23/2024Next Earnings (Estimated)5/02/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Prepackaged software Sub-IndustryN/A Current SymbolNASDAQ:DH CUSIPN/A CIK1861795 Webwww.definitivehc.com Phone508-720-4224FaxN/AEmployees950Year FoundedN/APrice Target and Rating Average Stock Price Target$11.31 High Stock Price Target$15.00 Low Stock Price Target$9.50 Potential Upside/Downside+55.6%Consensus RatingHold Rating Score (0-4)2.22 Research Coverage9 Analysts Profitability EPS (Most Recent Fiscal Year)($1.78) Trailing P/E RatioN/A Forward P/E Ratio66.09 P/E Growth6.15Net Income$-202,390,000.00 Net Margins-80.40% Pretax Margin-122.58% Return on Equity0.43% Return on Assets0.29% Debt Debt-to-Equity Ratio0.20 Current Ratio2.31 Quick Ratio2.31 Sales & Book Value Annual Sales$251.41 million Price / Sales3.41 Cash Flow$3.19 per share Price / Cash Flow2.28 Book Value$10.31 per share Price / Book0.71Miscellaneous Outstanding Shares117,790,000Free Float99,803,000Market Cap$856.33 million OptionableNot Optionable Beta1.39 7 AI Stocks to Invest In: An Introduction to AI Investing For Self-Directed InvestorsAs the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.Get This Free Report Key ExecutivesMr. Jason Ronald Krantz (Age 50)Founder, Executive Chairman & Interim CEO Comp: $130.38kMr. Jonathan Maack (Age 45)President Comp: $687.21kMr. Richard Douglas Booth (Age 55)Chief Financial Officer Comp: $579.47kMs. Kate Marie Shamsuddin Jensen (Age 37)Chief Product Officer Comp: $431.86kMs. Carrie Lazorchak (Age 54)Chief Revenue Officer Comp: $110.49kMr. Scott OberlinkChief Technology OfficerMr. Matthew RudermanChief Legal Officer & SecretaryMr. Craig HazenfieldChief People OfficerMr. Ram SharmaExecutive Vice President of Life SciencesMore ExecutivesKey CompetitorsTuyaNYSE:TUYAExpensifyNASDAQ:EXFYLivePersonNASDAQ:LPSNEverCommerceNASDAQ:EVCMSemrushNASDAQ:SEMRView All CompetitorsInsiders & InstitutionsWesbanco Bank Inc.Bought 69,000 shares on 4/23/2024Ownership: 0.059%Raymond James & AssociatesBought 248,266 shares on 4/22/2024Ownership: 0.717%Berry Wealth Group LPBought 12,323 shares on 4/22/2024Ownership: 0.010%Norden Group LLCBought 10,245 shares on 4/19/2024Ownership: 0.009%Tower Research Capital LLC TRC Bought 4,959 shares on 2/13/2024Ownership: 0.005%View All Insider TransactionsView All Institutional Transactions DH Stock Analysis - Frequently Asked Questions Should I buy or sell Definitive Healthcare stock right now? 9 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Definitive Healthcare in the last twelve months. There are currently 7 hold ratings and 2 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "hold" DH shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in DH, but not buy additional shares or sell existing shares. View DH analyst ratings or view top-rated stocks. What is Definitive Healthcare's stock price target for 2024? 9 Wall Street research analysts have issued 12-month target prices for Definitive Healthcare's stock. Their DH share price targets range from $9.50 to $15.00. On average, they expect the company's share price to reach $11.31 in the next year. This suggests a possible upside of 55.6% from the stock's current price. View analysts price targets for DH or view top-rated stocks among Wall Street analysts. How have DH shares performed in 2024? Definitive Healthcare's stock was trading at $9.94 at the start of the year. Since then, DH shares have decreased by 26.9% and is now trading at $7.27. View the best growth stocks for 2024 here. Are investors shorting Definitive Healthcare? Definitive Healthcare saw a increase in short interest during the month of March. As of March 31st, there was short interest totaling 7,440,000 shares, an increase of 54.0% from the March 15th total of 4,830,000 shares. Based on an average daily trading volume, of 554,800 shares, the days-to-cover ratio is currently 13.4 days. Approximately 15.6% of the company's shares are sold short. View Definitive Healthcare's Short Interest. When is Definitive Healthcare's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Thursday, May 2nd 2024. View our DH earnings forecast. How were Definitive Healthcare's earnings last quarter? Definitive Healthcare Corp. (NASDAQ:DH) issued its quarterly earnings results on Wednesday, February, 28th. The company reported ($0.01) earnings per share for the quarter, missing analysts' consensus estimates of $0.01 by $0.02. The company earned $65.93 million during the quarter, compared to analyst estimates of $66.01 million. Definitive Healthcare had a positive trailing twelve-month return on equity of 0.43% and a negative net margin of 80.40%. What ETFs hold Definitive Healthcare's stock? ETFs with the largest weight of Definitive Healthcare (NASDAQ:DH) stock in their portfolio include Fidelity Digital Health ETF (FDHT) and Global X Telemedicine & Digital Health ETF (EDOC).First Trust Nasdaq Lux Digital Health Solutions ETF (EKG). What guidance has Definitive Healthcare issued on next quarter's earnings? Definitive Healthcare updated its first quarter 2024 earnings guidance on Wednesday, February, 28th. The company provided earnings per share (EPS) guidance of 0.070-0.080 for the period, compared to the consensus estimate of 0.070. The company issued revenue guidance of $63.0 million-$65.0 million, compared to the consensus revenue estimate of $65.7 million. When did Definitive Healthcare IPO? Definitive Healthcare (DH) raised $350 million in an IPO on Wednesday, September 15th 2021. The company issued 15,555,555 shares at $21.00-$24.00 per share. Who are Definitive Healthcare's major shareholders? Definitive Healthcare's stock is owned by a variety of retail and institutional investors. Top institutional shareholders include Raymond James & Associates (0.72%), Wesbanco Bank Inc. (0.06%), Berry Wealth Group LP (0.01%) and Norden Group LLC (0.01%). Insiders that own company stock include David Randall Winn, Jeffrey Charles Haywood, Richard Douglas Booth and Sea Vii Management, Llc. View institutional ownership trends. How do I buy shares of Definitive Healthcare? Shares of DH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:DH) was last updated on 4/24/2024 by MarketBeat.com Staff From Our PartnersThis Apple-like Innovator is Revolutionizing HealthcareWall Street StarThe A.I. story nobody is telling you (Read ASAP)TradeSmithtop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencySHOCKING Crypto Leak…Crypto 101 MediaDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsEmergency: Biden's $20 Trillion Mistake Could Cost YOU!GoldenCrest MetalsThe #1 Crypto for 2024InvestorPlaceDon’t Miss Out on the AI Gold Rush That’s Just Getting StartedBanyan Hill Publishing Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Definitive Healthcare Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
